The hyaluronan/CD44 axis: a double-edged sword in cancer

N Cirillo - International Journal of Molecular Sciences, 2023 - mdpi.com
Hyaluronic acid (HA) receptor CD44 is widely used for identifying cancer stem cells and its
activation promotes stemness. Recent evidence shows that overexpression of CD44 is …

Aptamers as potential therapeutic tools for ovarian cancer: Advancements and challenges

W Szymanowski, A Szymanowska, A Bielawska… - Cancers, 2023 - mdpi.com
Simple Summary Aptamers are versatile molecules for cancer treatment. They can be used
to target specific molecules, conjugated to additional nucleic acid moieties or payloads. In …

A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients

K Yuan, S Zhao, B Ye, Q Wang, Y Liu… - Frontiers in …, 2023 - frontiersin.org
The phenomenon of T Cell exhaustion (TEX) entails a progressive deterioration in the
functionality of T cells within the immune system during prolonged conflicts with chronic …

Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells

R El Baba, S Haidar Ahmad, F Monnien, R Mansar… - Oncogene, 2023 - nature.com
Human cytomegalovirus (HCMV) infection has been implicated in epithelial ovarian cancer
(OC). Polyploidy giant cancer cells (PGCCs) have been observed in high-grade serous …

Ginsenoside Rh1 prevents migration and invasion through mitochondrial ROS-mediated inhibition of STAT3/NF-κB signaling in MDA-MB-231 cells

Y Jin, DTN Huynh, CS Myung, KS Heo - International journal of molecular …, 2021 - mdpi.com
Breast cancer (BC) a very common cancer in women worldwide. Triple negative breast
cancer (TNBC) has been shown to have a poor prognosis with a high level of tumor …

HAPLN1 potentiates peritoneal metastasis in pancreatic cancer

L Wiedmann, F De Angelis Rigotti… - Nature …, 2023 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) frequently metastasizes into the peritoneum,
which contributes to poor prognosis. Metastatic spreading is promoted by cancer cell …

Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis

N Iżycka, MP Zaborowski, Ł Ciecierski, K Jaz… - International Journal of …, 2023 - mdpi.com
Cancer stem cells (CSCs) may contribute to an increased risk of recurrence in ovarian
cancer (OC). Further research is needed to identify associations between CSC markers and …

[HTML][HTML] Mitochondrial dynamics mediated by DRP1 and MFN2 contributes to cisplatin chemoresistance in human ovarian cancer SKOV3 cells

GP Zou, CX Yu, SL Shi, QG Li, XH Wang, XH Qu… - Journal of …, 2021 - ncbi.nlm.nih.gov
Cisplatin (DDP) is the first-line chemotherapeutic agent for ovarian cancer. However, the
development of DDP resistance seriously influences the chemotherapeutic effect and …

Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy

B Jing, F Guo, R An, Y Gao, Y Li, Y Xie, J Wang… - Journal of …, 2023 - Springer
Abstract Background Cancer stem cells (CSCs) are crucial for the growth, metastasis, drug
resistance, recurrence, and spread of tumors. Napabucasin (NAP) could effectively inhibit …

Therapeutic strategies for targeting ovarian cancer stem cells

W Yang, D Kim, DK Kim, KU Choi, DS Suh… - International Journal of …, 2021 - mdpi.com
Ovarian cancer is a fatal gynecological malignancy. Although first-line chemotherapy and
surgical operation are effective treatments for ovarian cancer, its clinical management …